Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme

Updated daily

Drug recalls

Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.

Class IITerminatedMar 8, 2023Pravastatin Sodium Tablets USPCGMP Deviations: recalling drug products following an FDA inspection.Accord Healthcare, Inc. · D-0421-2023Class IITerminatedMar 8, 2023Pirfenidone Tablets 801 mgCGMP Deviations: recalling drug products following an FDA inspection.Accord Healthcare, Inc. · D-0420-2023Class IITerminatedMar 8, 2023Pirfenidone Tablets 267 mgCGMP Deviations: recalling drug products following an FDA inspection.Accord Healthcare, Inc. · D-0419-2023Class IITerminatedMar 8, 2023Vigabatrin for Oral SolutionCGMP Deviations: recalling drug products following an FDA inspection.Accord Healthcare, Inc. · D-0418-2023Class IITerminatedMar 8, 2023Tadalafil TabletsCGMP Deviations: recalling drug products following an FDA inspection.Accord Healthcare, Inc. · D-0417-2023Class IITerminatedMar 8, 2023Tadalafil TabletsCGMP Deviations: recalling drug products following an FDA inspection.Accord Healthcare, Inc. · D-0416-2023Class IITerminatedMar 8, 2023Tadalafil TabletsCGMP Deviations: recalling drug products following an FDA inspection.Accord Healthcare, Inc. · D-0415-2023Class IITerminatedMar 8, 2023Tadalafil TabletsCGMP Deviations: recalling drug products following an FDA inspection.Accord Healthcare, Inc. · D-0414-2023Class IITerminatedMar 8, 2023Succinylcholine Chloride InjectionCGMP Deviations: recalling drug products following an FDA inspection.Accord Healthcare, Inc. · D-0413-2023Class IITerminatedMar 8, 2023Simvastatin Tablets USP 80 mgCGMP Deviations: recalling drug products following an FDA inspection.Accord Healthcare, Inc. · D-0412-2023Class IITerminatedMar 8, 2023Simvastatin Tablets USP 40 mgCGMP Deviations: recalling drug products following an FDA inspection.Accord Healthcare, Inc. · D-0411-2023Class IITerminatedMar 8, 2023Simvastatin Tablets USP 20 mgCGMP Deviations: recalling drug products following an FDA inspection.Accord Healthcare, Inc. · D-0410-2023Class IITerminatedMar 8, 2023Simvastatin TabletsCGMP Deviations: recalling drug products following an FDA inspection.Accord Healthcare, Inc. · D-0409-2023Class IITerminatedMar 8, 2023Simvastatin Tablets USP 5 mgCGMP Deviations: recalling drug products following an FDA inspection.Accord Healthcare, Inc. · D-0408-2023Class IITerminatedMar 8, 2023Rosuvastatin TabletsCGMP Deviations: recalling drug products following an FDA inspection.Accord Healthcare, Inc. · D-0407-2023Class IITerminatedMar 8, 2023Rosuvastatin TabletsCGMP Deviations: recalling drug products following an FDA inspection.Accord Healthcare, Inc. · D-0406-2023Class IITerminatedMar 8, 2023Rosuvastatin TabletsCGMP Deviations: recalling drug products following an FDA inspection.Accord Healthcare, Inc. · D-0405-2023Class IITerminatedMar 8, 2023Rosuvastatin TabletsCGMP Deviations: recalling drug products following an FDA inspection.Accord Healthcare, Inc. · D-0404-2023Class IITerminatedMar 8, 2023Phenylephrine Hydrochloride InjectionCGMP Deviations: recalling drug products following an FDA inspection.Accord Healthcare, Inc. · D-0403-2023Class IITerminatedMar 8, 2023Phenylephrine Hydrochloride InjectionCGMP Deviations: recalling drug products following an FDA inspection.Accord Healthcare, Inc. · D-0402-2023Class IITerminatedMar 8, 2023Phenylephrine Hydrochloride InjectionCGMP Deviations: recalling drug products following an FDA inspection.Accord Healthcare, Inc. · D-0401-2023Class IITerminatedMar 8, 2023Montelukast Sodium TabletsCGMP Deviations: recalling drug products following an FDA inspection.Accord Healthcare, Inc. · D-0400-2023Class IITerminatedMar 8, 2023Glycopyrrolate InjectionCGMP Deviations: recalling drug products following an FDA inspection.Accord Healthcare, Inc. · D-0399-2023Class IITerminatedMar 8, 2023Glycopyrrolate InjectionCGMP Deviations: recalling drug products following an FDA inspection.Accord Healthcare, Inc. · D-0398-2023Class IITerminatedMar 8, 2023Glycopyrrolate InjectionCGMP Deviations: recalling drug products following an FDA inspection.Accord Healthcare, Inc. · D-0397-2023Class IITerminatedMar 8, 2023Glycopyrrolate InjectionCGMP Deviations: recalling drug products following an FDA inspection.Accord Healthcare, Inc. · D-0396-2023Class IITerminatedMar 8, 2023Glimepiride Tablets USPCGMP Deviations: recalling drug products following an FDA inspection.Accord Healthcare, Inc. · D-0395-2023Class IITerminatedMar 8, 2023Glimepiride Tablets USPCGMP Deviations: recalling drug products following an FDA inspection.Accord Healthcare, Inc. · D-0394-2023Class IITerminatedMar 8, 2023Glimepiride Tablets USPCGMP Deviations: recalling drug products following an FDA inspection.Accord Healthcare, Inc. · D-0393-2023Class IITerminatedMar 8, 2023Finasteride Tablets USPCGMP Deviations: recalling drug products following an FDA inspection.Accord Healthcare, Inc. · D-0392-2023Class IITerminatedMar 8, 2023Finasteride Tablets USP 1 mgCGMP Deviations: recalling drug products following an FDA inspection.Accord Healthcare, Inc. · D-0391-2023Class IITerminatedMar 8, 2023Finasteride Tablets USPCGMP Deviations: recalling drug products following an FDA inspection.Accord Healthcare, Inc. · D-0390-2023Class IITerminatedMar 8, 2023Doxazosin Tablets USPCGMP Deviations: recalling drug products following an FDA inspection.Accord Healthcare, Inc. · D-0389-2023Class IITerminatedMar 8, 2023Doxazosin Tablets USPCGMP Deviations: recalling drug products following an FDA inspection.Accord Healthcare, Inc. · D-0388-2023Class IITerminatedMar 8, 2023Doxazosin Tablets USPCGMP Deviations: recalling drug products following an FDA inspection.Accord Healthcare, Inc. · D-0387-2023Class IITerminatedMar 8, 2023Doxazosin Tablets USP 1 mgCGMP Deviations: recalling drug products following an FDA inspection.Accord Healthcare, Inc. · D-0386-2023Class IITerminatedMar 8, 2023Dofetilide Capsules 500 mcgCGMP Deviations: recalling drug products following an FDA inspection.Accord Healthcare, Inc. · D-0385-2023Class IITerminatedMar 8, 2023Dofetilide Capsules 250 mcgCGMP Deviations: recalling drug products following an FDA inspection.Accord Healthcare, Inc. · D-0384-2023Class IITerminatedMar 8, 2023Dofetilide CapsulesCGMP Deviations: recalling drug products following an FDA inspection.Accord Healthcare, Inc. · D-0383-2023Class IITerminatedMar 8, 2023Daptomycin for Injection 500 mg per vialCGMP Deviations: recalling drug products following an FDA inspection.Accord Healthcare, Inc. · D-0382-2023

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.